Variable Patterns of Remission from ADHD in the Multimodal Treatment Study of ADHD

Margaret H Sibley, L Eugene Arnold, James M Swanson, Lily T Hechtman, Traci M Kennedy, Elizabeth Owens, Brooke S G Molina, Peter S Jensen, Stephen P Hinshaw, Arunima Roy, Andrea Chronis-Tuscano, Jeffrey H Newcorn, Luis A Rohde, MTA Cooperative Group (2022)

American Journal of Psychiatry 179(2), 142-151

Abstract

OBJECTIVE: It is estimated that childhood ADHD remits by adulthood in approximately 50% of cases; however, this conclusion is typically based on single endpoints, failing to consider longitudinal patterns of ADHD expression. We investigated the extent to which children with ADHD experience recovery and variable patterns of remission by adulthood. METHOD: Children with ADHD (N=558) in the Multimodal Treatment Study of ADHD (MTA) were administered eight assessments from 2-year (M age=10.44) to 16-year follow-up (M age=25.12). We identified participants with fully remitted, partially remitted, and persistent ADHD at each timepoint based on parent, teacher, and self-reports of ADHD symptoms and impairment, treatment utilization, and substance use and mental disorders. Longitudinal patterns of remission and persistence were identified that considered context and timing. RESULTS: Approximately 30% of children with ADHD experienced full remission at some point during the 14-year follow-up period; however, a majority (60% of these) experienced recurrence of ADHD after the initial period of remission. Only 9.1% of the sample demonstrated recovery (sustained remission) by study endpoint and only 10.8% demonstrated stable ADHD persistence across study timepoints. Instead, most participants with ADHD (63.8%) had fluctuating periods of remission and recurrence over time. CONCLUSIONS: The MTA findings challenge the notion that approximately 50% of children with ADHD outgrow the disorder by adulthood. Most cases demonstrated fluctuating symptoms between childhood and young adulthood. Although intermittent periods of remission can be expected in most cases, 90% of children with ADHD continued to struggle with residual ADHD through young adulthood. Clinical Trial Number: NCT00000388, Multimodal Treatment Study of Children with Attention Deficit and Hyperactivity Disorder (MTA). https://clinicaltrials.gov/ct2/ show/NCT00000388

Categories: ADHS bei Erwachsenen, ADHS bei Kindern

Keywords: ADHD, remission, recurrence, recovery, longitudinal course, MTA

Diese Publikation auf Deutsch

Nach oben scrollen